• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射后,双歧双歧杆菌在小鼠肿瘤中的选择性定位与生长。

Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration.

作者信息

Kimura N T, Taniguchi S, Aoki K, Baba T

出版信息

Cancer Res. 1980 Jun;40(6):2061-8.

PMID:6989495
Abstract

A strain of domestic bacteria, Bifidobacterium bifidum (Lac B), which is nonpathogenic and anerobic, selectively localized and proliferated in several types of mouse tumors following i.v. administration. None of the same bacilli could be detected in the tissues of healthy organs such as the liver, spleen, kidney, lung, blood, bone marrow, and muscle 48 or 96 hr after i.v. administration into tumor-bearing mice. Proliferation of Lac B in the tumor was artifically stimulated by i.p. administration of DDD-H-2s mice of a synthesized disaccharide, lactulose (4-O-beta-D-galactopyranosyl-D-fructofuranose), a sugar which is not metabolized by mammalian tissue cells. Lac B, which survices and proliferates selectively in the tumor following i.v. administration into the tumor-bearing host, should aid in diagnosis and selective therapy for cancer.

摘要

一种国内菌株,双歧双歧杆菌(Lac B),它无致病性且厌氧,在静脉注射后能在几种类型的小鼠肿瘤中选择性地定位并增殖。给荷瘤小鼠静脉注射后48或96小时,在肝脏、脾脏、肾脏、肺、血液、骨髓和肌肉等健康器官的组织中均未检测到相同的杆菌。通过腹腔注射合成二糖乳果糖(4-O-β-D-吡喃半乳糖基-D-呋喃果糖)对DDD-H-2s小鼠进行人工刺激,可促进Lac B在肿瘤中的增殖,乳果糖是一种哺乳动物组织细胞不能代谢的糖。Lac B在静脉注射到荷瘤宿主后能在肿瘤中选择性存活和增殖,这应该有助于癌症的诊断和选择性治疗。

相似文献

1
Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration.静脉注射后,双歧双歧杆菌在小鼠肿瘤中的选择性定位与生长。
Cancer Res. 1980 Jun;40(6):2061-8.
2
Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors.长双歧杆菌作为癌症基因治疗的递送系统:在缺氧肿瘤中的选择性定位与生长
Cancer Gene Ther. 2000 Feb;7(2):269-74. doi: 10.1038/sj.cgt.7700122.
3
Purine nucleotide levels in host tissues of Ehrlich ascites tumor-bearing mice in different growth phases of the tumor.艾氏腹水瘤荷瘤小鼠宿主组织在肿瘤不同生长阶段的嘌呤核苷酸水平。
Cancer Res. 1993 Nov 1;53(21):5143-7.
4
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.顺式二氯(2-甲基吡啶)氨铂(II)(AMD473),一种新型空间位阻铂配合物:小鼠体内活性、毒理学及药代动力学
Clin Cancer Res. 1997 Nov;3(11):2063-74.
5
Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.125I标记的B淋巴细胞刺激因子在小鼠体内快速且特异性地靶向淋巴组织和B细胞肿瘤。
J Nucl Med. 2003 Mar;44(3):422-33.
6
Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.利用抗体-白细胞介素2融合蛋白对转基因小鼠中表达癌胚抗原的肿瘤进行靶向治疗
Cancer Res. 2000 Aug 15;60(16):4475-84.
7
Tissue distribution and tumor localization of effector cells in adoptive immunotherapy of cancer.癌症过继性免疫治疗中效应细胞的组织分布与肿瘤定位
APMIS Suppl. 1995;55:1-28.
8
Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts.17-去甲氧基-17-[[(2-二甲氨基)乙基]氨基]格尔德霉素(17DMAG,NSC 707545)在携带MDA-MB-231人乳腺癌异种移植瘤的C.B-17 SCID小鼠体内的药代动力学和药效学
Cancer Chemother Pharmacol. 2005 Jan;55(1):21-32. doi: 10.1007/s00280-004-0865-3. Epub 2004 Aug 27.
9
Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.人前列腺癌转移至人骨的严重联合免疫缺陷-人模型
Cancer Res. 1999 Apr 15;59(8):1987-93.
10
Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth.青春双歧杆菌作为内皮抑素用于癌症基因治疗的递送系统:血管生成和缺氧肿瘤生长的选择性抑制剂。
Cancer Gene Ther. 2003 Feb;10(2):105-11. doi: 10.1038/sj.cgt.7700530.

引用本文的文献

1
Engineered Strains Colonization at Tumor Sites: A Novel Approach to the Delivery of Cancer Treatments.工程菌株在肿瘤部位的定殖:一种癌症治疗递送的新方法。
Cancers (Basel). 2025 Jul 28;17(15):2487. doi: 10.3390/cancers17152487.
2
Application of bifidobacterium in tumor therapy.双歧杆菌在肿瘤治疗中的应用。
Front Oncol. 2025 May 15;15:1551924. doi: 10.3389/fonc.2025.1551924. eCollection 2025.
3
Bacteria-Assisted Celastrol Liposomes for Effective Chemotherapy Against Lung Cancer in Mice Model.细菌辅助的雷公藤红素脂质体用于在小鼠模型中有效化疗肺癌
Int J Nanomedicine. 2025 Apr 15;20:4645-4660. doi: 10.2147/IJN.S514064. eCollection 2025.
4
Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape?肿瘤内微生物组:重塑肿瘤微环境景观的敌人还是朋友?
Cells. 2024 Jul 30;13(15):1279. doi: 10.3390/cells13151279.
5
Promising dawn in tumor microenvironment therapy: engineering oral bacteria.肿瘤微环境治疗的曙光:工程口腔细菌。
Int J Oral Sci. 2024 Mar 13;16(1):24. doi: 10.1038/s41368-024-00282-3.
6
Tumor-homing bacterium-adsorbed liposomes encapsulating perfluorohexane/doxorubicin enhance pulsed-focused ultrasound for tumor therapy.负载全氟己烷/阿霉素的肿瘤靶向细菌吸附脂质体增强脉冲聚焦超声用于肿瘤治疗。
RSC Adv. 2023 Jun 23;13(28):19065-19078. doi: 10.1039/d3ra01876h. eCollection 2023 Jun 22.
7
Nanomedicines for high‑intensity focused ultrasound cancer treatment and theranostics (Review).用于高强度聚焦超声癌症治疗及诊疗一体化的纳米药物(综述)
Exp Ther Med. 2023 Mar 3;25(4):170. doi: 10.3892/etm.2023.11869. eCollection 2023 Apr.
8
JCM1395 Achieved Intratumoral Growth with Minimal Inflammation: Evidence for Live Bacterial Therapeutic Potential by an Optimized Sample Preparation and Colony PCR Method.JCM1395实现瘤内生长且炎症轻微:通过优化样本制备和菌落PCR方法证明活细菌的治疗潜力
Pharmaceutics. 2023 Mar 19;15(3):989. doi: 10.3390/pharmaceutics15030989.
9
Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.宿主微生物组的区室化:肿瘤微生物组如何塑造检查点免疫治疗的结果并提供治疗前景。
J Immunother Cancer. 2022 Nov;10(11). doi: 10.1136/jitc-2022-005401.
10
US/MR Bimodal Imaging-Guided Bio-Targeting Synergistic Agent for Tumor Therapy.美国/磁共振双模态成像引导的肿瘤治疗协同靶向生物试剂
Int J Nanomedicine. 2022 Jul 4;17:2943-2960. doi: 10.2147/IJN.S363645. eCollection 2022.